Preclinical development of a neutral, estrogen receptor-targeted, tridentate 99mTc(I)-estradiol-pyridin-2-yl hydrazine derivative for imaging of breast and endometrial cancers. (Q36731191)
Jump to navigation
Jump to search
scientific article published on 15 May 2008
Language | Label | Description | Also known as |
---|---|---|---|
English | Preclinical development of a neutral, estrogen receptor-targeted, tridentate 99mTc(I)-estradiol-pyridin-2-yl hydrazine derivative for imaging of breast and endometrial cancers. |
scientific article published on 15 May 2008 |
Statements
Preclinical development of a neutral, estrogen receptor-targeted, tridentate 99mTc(I)-estradiol-pyridin-2-yl hydrazine derivative for imaging of breast and endometrial cancers (English)
Helen J Hathaway
Chinnasamy Ramesh
Jeffrey B Arterburn
Donghai Dai
Jeffrey P Norenberg
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference